News

Endo fails in FDA law suit to stop generic Opana ER in USA; Mylan settles with Orion

21-12-2012

The US District Judge Reggie Walton, of the District Court for the District of Columbia, has dismissed…

ActavisComtanEndo PharmaceuticalsGenericsImpax LaboratoriesLegalMylan LaboratoriesNeurologicalNorth AmericaOpana ERPharmaceutical

US patent settlements of Xopenex and Lidoderm

30-05-2012

US generics drug major Mylan (Nasdaq: MYL) has entered into a settlement agreement with Sunovion Pharmaceuticals,…

Dainippon Sumitomo PharmaEndo PharmaceuticalsGenericsLidodermMylan LaboratoriesNeurologicalNorth AmericaPatentsRespiratory and PulmonarySunovionWatson PharmaceuticalsXopenex

Endo Pharma sues Mylan over Frova patent infringement

17-08-2011

US generic drugmaker Mylan (Nasdaq: MYL) yesterday confirmed that the company and its subsidiary Mylan…

Endo PharmaceuticalsFrovaFrovatriptan SuccinateGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaRegulation

Vernalis' losses for 1st-half 2006 down slightly

18-09-2006

UK biotechnology firm Vernalis says that its losses for the six months ended June 30, 2006, were L19.4…

AlphaAmino AcidsApokynApomorphineBiogen IdecDoparEndo PharmaceuticalsFrovaFrovatriptan SuccinateInjectionLevodopaMylan LaboratoriesNovartisPhysostigmine SalicylateProlastin

COMPANY SPOTLIGHT

Menarini

Back to top